Reply: Suicidality in Huntington's Disease: Distinguishing lithium from other psychotropic medications. | Mov Disord;30(10): 1438-9, 2015 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Nursing VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Reply: Suicidality in Huntington's Disease: Distinguishing lithium from other psychotropic medications.

Moulton, Calum D; Hopkins, C W P; Bevan-Jones, W Richard.

Affiliation

Moulton CD; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College, London.
Hopkins CW; Oxford Health NHS Foundation Trust, UK.
Bevan-Jones WR; Bristol Institute of Clinical Neurosciences, UK.

Mov Disord ; 30(10): 1438-9, 2015 Sep.

Article in En | MEDLINE | ID: mdl-26010142

Subject(s)

Antidepressive Agents/therapeutic use; Depression/drug therapy; Depression/etiology; Huntington Disease/complications; Humans

Search on Google

Full text: 1 Database: MEDLINE Main subject: Huntington Disease / Depression / Antidepressive Agents Limits: Humans Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2015 Type: Article

Search on Google

Full text: 1 Database: MEDLINE Main subject: Huntington Disease / Depression / Antidepressive Agents Limits: Humans Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2015 Type: Article